Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-000175

President and COO sold 8,000 shares at $10.58 ($84,654)

  • President and COO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Larson Tina Marriott · President and COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-28 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $1.06 $8,480 422,548 D
2023-12-28 Sale : show line 2 in the form 10b5-1 −8,000 $10.58 $84,654 414,548 D
Open-market sales · 8,000 sh · avg $10.58 · $84,654

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-12-28 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −8,000 $1.06 2028-07-22 8,000 512,000 D
Loading xslF345X05/doc4.xml…